
- /
- Supported exchanges
- / CO
- / CHEMM.CO
ChemoMetec A/S (CHEMM CO) stock market data APIs
ChemoMetec A/S Financial Data Overview
ChemoMetec A/S engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally. The company offers its solutions in the areas of cell and gene therapy, cancer and stem cell research, and development and manufacturing of pharmaceuticals, as well as production and quality control of animal semen, milk, and beer. Its products include NucleoCounter NC-3000, an advanced image cytometer; NucleoCounter NC-250, an automated cell analyzer; NucleoCounter NC-202, a consistent cell counter; NucleoCounter NC-200, an automated cell counter that provides solution for cell counting and cell viability determination; NucleoCounter SP-100, an automated sperm cell counter for use in animal reproduction; and XcytoMatic 40, a cell density and viability analyzer. In addition, the company provides consumables comprising cassettes, reagents, lysis, and slides; accessories, which include cables, power supplies, software, and labware products, as well as service and validation plans and training. Further, it develops as well as develops XcytoMatic 30 cell counter. ChemoMetec A/S was incorporated in 1997 and is headquartered in Allerød, Denmark.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get ChemoMetec A/S data using free add-ons & libraries
Get ChemoMetec A/S Fundamental Data
ChemoMetec A/S Fundamental data includes:
- Net Revenue: 460 M
- EBITDA: 220 M
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-05-07
- EPS/Forecast: 3.47
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
ChemoMetec A/S News

3 Undiscovered European Gems Including ChemoMetec
As European markets navigate the turbulence of intensified global trade tensions, with the pan-European STOXX Europe 600 Index recently ending 1.92% lower, investors are increasingly vigilant about th...


Martin Glensbjerg takes up new position at ChemoMetec
Chemometec A/S ANNOUNCEMENT NO. 248 20 December 2023 Martin Glensbjerg takes up a new role in ChemoMetec COO and deputy chairman of the board Martin Glensbjerg has decided to step down in ChemoMet...

Q1 2023/24 - Lower revenue in a challenging market
ANNOUNCEMENT NO. 247 Trading statement for Q1 2023/24 (1 July - 30 September 2023) Lower revenue in a challenging market Revenue for the first quarter of 2023/24 was, as expected, affected by conti...

Q1 2023/24 - Lower revenue in a challenging market
Chemometec A/S ANNOUNCEMENT NO. 247 Trading statement for Q1 2023/24 (1 July - 30 September 2023) Lower revenue in a challenging market Revenue for the first quarter of 2023/24 was, as expected, a...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.